The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Natural Killer Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Natural Killer Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Natural Killer Cell Therapy market size is estimated to be worth US$ 263.2 million in 2021 and is forecast to a readjusted size of USD 1131.3 million by 2028 with a CAGR of 23.2% during review period. Cancer accounting for % of the Natural Killer Cell Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While NK Cell Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, and Glycostem Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Natural Killer Cell Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application, can be divided into
Cancer
Gastrointestinal Diseases
Others
Market segment by players, this report covers
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Natural Killer Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Natural Killer Cell Therapy, with revenue, gross margin and global market share of Natural Killer Cell Therapy from 2019 to 2022.
Chapter 3, the Natural Killer Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Natural Killer Cell Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Natural Killer Cell Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
The Natural Killer Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Natural Killer Cell Therapy market size is estimated to be worth US$ 263.2 million in 2021 and is forecast to a readjusted size of USD 1131.3 million by 2028 with a CAGR of 23.2% during review period. Cancer accounting for % of the Natural Killer Cell Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While NK Cell Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, and Glycostem Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Natural Killer Cell Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application, can be divided into
Cancer
Gastrointestinal Diseases
Others
Market segment by players, this report covers
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Natural Killer Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Natural Killer Cell Therapy, with revenue, gross margin and global market share of Natural Killer Cell Therapy from 2019 to 2022.
Chapter 3, the Natural Killer Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Natural Killer Cell Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Natural Killer Cell Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Natural Killer Cell Therapy
1.2 Classification of Natural Killer Cell Therapy by Type
1.2.1 Overview: Global Natural Killer Cell Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Natural Killer Cell Therapy Revenue Market Share by Type in 2021
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global Natural Killer Cell Therapy Market by Application
1.3.1 Overview: Global Natural Killer Cell Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Global Natural Killer Cell Therapy Market Size & Forecast
1.5 Global Natural Killer Cell Therapy Market Size and Forecast by Region
1.5.1 Global Natural Killer Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Natural Killer Cell Therapy Market Size by Region, (2017-2022)
1.5.3 North America Natural Killer Cell Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Natural Killer Cell Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Natural Killer Cell Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Natural Killer Cell Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Natural Killer Cell Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Natural Killer Cell Therapy Market Drivers
1.6.2 Natural Killer Cell Therapy Market Restraints
1.6.3 Natural Killer Cell Therapy Trends Analysis
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Nektar Therapeutics Details
2.1.2 Nektar Therapeutics Major Business
2.1.3 Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions
2.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Nektar Therapeutics Recent Developments and Future Plans
2.2 Innate Pharma SA
2.2.1 Innate Pharma SA Details
2.2.2 Innate Pharma SA Major Business
2.2.3 Innate Pharma SA Natural Killer Cell Therapy Product and Solutions
2.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Innate Pharma SA Recent Developments and Future Plans
2.3 Affimed
2.3.1 Affimed Details
2.3.2 Affimed Major Business
2.3.3 Affimed Natural Killer Cell Therapy Product and Solutions
2.3.4 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Affimed Recent Developments and Future Plans
2.4 Chipscreen Biosciences
2.4.1 Chipscreen Biosciences Details
2.4.2 Chipscreen Biosciences Major Business
2.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions
2.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Chipscreen Biosciences Recent Developments and Future Plans
2.5 Glycostem Therapeutics
2.5.1 Glycostem Therapeutics Details
2.5.2 Glycostem Therapeutics Major Business
2.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions
2.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Glycostem Therapeutics Recent Developments and Future Plans
2.6 Fate Therapeutics
2.6.1 Fate Therapeutics Details
2.6.2 Fate Therapeutics Major Business
2.6.3 Fate Therapeutics Natural Killer Cell Therapy Product and Solutions
2.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Fate Therapeutics Recent Developments and Future Plans
2.7 Dragonfly Therapeutics
2.7.1 Dragonfly Therapeutics Details
2.7.2 Dragonfly Therapeutics Major Business
2.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions
2.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Dragonfly Therapeutics Recent Developments and Future Plans
2.8 Kiadis Pharma
2.8.1 Kiadis Pharma Details
2.8.2 Kiadis Pharma Major Business
2.8.3 Kiadis Pharma Natural Killer Cell Therapy Product and Solutions
2.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Kiadis Pharma Recent Developments and Future Plans
2.9 Nkarta Therapeutics
2.9.1 Nkarta Therapeutics Details
2.9.2 Nkarta Therapeutics Major Business
2.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions
2.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Nkarta Therapeutics Recent Developments and Future Plans
2.10 NantKwest
2.10.1 NantKwest Details
2.10.2 NantKwest Major Business
2.10.3 NantKwest Natural Killer Cell Therapy Product and Solutions
2.10.4 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 NantKwest Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Natural Killer Cell Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Natural Killer Cell Therapy Players Market Share in 2021
3.2.2 Top 10 Natural Killer Cell Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Natural Killer Cell Therapy Players Head Office, Products and Services Provided
3.4 Natural Killer Cell Therapy Mergers & Acquisitions
3.5 Natural Killer Cell Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Natural Killer Cell Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Natural Killer Cell Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Natural Killer Cell Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Natural Killer Cell Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Natural Killer Cell Therapy Revenue by Type (2017-2028)
6.2 North America Natural Killer Cell Therapy Revenue by Application (2017-2028)
6.3 North America Natural Killer Cell Therapy Market Size by Country
6.3.1 North America Natural Killer Cell Therapy Revenue by Country (2017-2028)
6.3.2 United States Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Natural Killer Cell Therapy Revenue by Type (2017-2028)
7.2 Europe Natural Killer Cell Therapy Revenue by Application (2017-2028)
7.3 Europe Natural Killer Cell Therapy Market Size by Country
7.3.1 Europe Natural Killer Cell Therapy Revenue by Country (2017-2028)
7.3.2 Germany Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
7.3.3 France Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Natural Killer Cell Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Natural Killer Cell Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Natural Killer Cell Therapy Revenue by Region (2017-2028)
8.3.2 China Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8.3.5 India Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Natural Killer Cell Therapy Revenue by Type (2017-2028)
9.2 South America Natural Killer Cell Therapy Revenue by Application (2017-2028)
9.3 South America Natural Killer Cell Therapy Market Size by Country
9.3.1 South America Natural Killer Cell Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Natural Killer Cell Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Natural Killer Cell Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Natural Killer Cell Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Natural Killer Cell Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Natural Killer Cell Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Natural Killer Cell Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Natural Killer Cell Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Natural Killer Cell Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Natural Killer Cell Therapy Revenue Market Share by Region (2023-2028)
Table 6. Nektar Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. Nektar Therapeutics Major Business
Table 8. Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 9. Nektar Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Innate Pharma SA Corporate Information, Head Office, and Major Competitors
Table 11. Innate Pharma SA Major Business
Table 12. Innate Pharma SA Natural Killer Cell Therapy Product and Solutions
Table 13. Innate Pharma SA Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Affimed Corporate Information, Head Office, and Major Competitors
Table 15. Affimed Major Business
Table 16. Affimed Natural Killer Cell Therapy Product and Solutions
Table 17. Affimed Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Chipscreen Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. Chipscreen Biosciences Major Business
Table 20. Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions
Table 21. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Glycostem Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Glycostem Therapeutics Major Business
Table 24. Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 25. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Fate Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Fate Therapeutics Major Business
Table 28. Fate Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 29. Fate Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Dragonfly Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Dragonfly Therapeutics Major Business
Table 32. Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 33. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Kiadis Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Kiadis Pharma Major Business
Table 36. Kiadis Pharma Natural Killer Cell Therapy Product and Solutions
Table 37. Kiadis Pharma Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Nkarta Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Nkarta Therapeutics Major Business
Table 40. Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 41. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. NantKwest Corporate Information, Head Office, and Major Competitors
Table 43. NantKwest Major Business
Table 44. NantKwest Natural Killer Cell Therapy Product and Solutions
Table 45. NantKwest Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Natural Killer Cell Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Natural Killer Cell Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Natural Killer Cell Therapy Players Head Office, Products and Services Provided
Table 50. Natural Killer Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 51. Natural Killer Cell Therapy New Entrants and Expansion Plans
Table 52. Global Natural Killer Cell Therapy Revenue (USD Million) by Type (2017-2022)
Table 53. Global Natural Killer Cell Therapy Revenue Share by Type (2017-2022)
Table 54. Global Natural Killer Cell Therapy Revenue Forecast by Type (2023-2028)
Table 55. Global Natural Killer Cell Therapy Revenue by Application (2017-2022)
Table 56. Global Natural Killer Cell Therapy Revenue Forecast by Application (2023-2028)
Table 57. North America Natural Killer Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Natural Killer Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Natural Killer Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Natural Killer Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Natural Killer Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Natural Killer Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Natural Killer Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Natural Killer Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Natural Killer Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Natural Killer Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Natural Killer Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Natural Killer Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Natural Killer Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Natural Killer Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Natural Killer Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Natural Killer Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Natural Killer Cell Therapy Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Natural Killer Cell Therapy Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Natural Killer Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Natural Killer Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Natural Killer Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Natural Killer Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Natural Killer Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Natural Killer Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Natural Killer Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Natural Killer Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Natural Killer Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Natural Killer Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Natural Killer Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Natural Killer Cell Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Natural Killer Cell Therapy Picture
Figure 2. Global Natural Killer Cell Therapy Revenue Market Share by Type in 2021
Figure 3. NK Cell Therapies
Figure 4. NK Cell Directed Antibodies
Figure 5. Natural Killer Cell Therapy Revenue Market Share by Application in 2021
Figure 6. Cancer Picture
Figure 7. Gastrointestinal Diseases Picture
Figure 8. Others Picture
Figure 9. Global Natural Killer Cell Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Natural Killer Cell Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Natural Killer Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 12. Global Natural Killer Cell Therapy Revenue Market Share by Region in 2021
Figure 13. North America Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Natural Killer Cell Therapy Market Drivers
Figure 19. Natural Killer Cell Therapy Market Restraints
Figure 20. Natural Killer Cell Therapy Market Trends
Figure 21. Nektar Therapeutics Recent Developments and Future Plans
Figure 22. Innate Pharma SA Recent Developments and Future Plans
Figure 23. Affimed Recent Developments and Future Plans
Figure 24. Chipscreen Biosciences Recent Developments and Future Plans
Figure 25. Glycostem Therapeutics Recent Developments and Future Plans
Figure 26. Fate Therapeutics Recent Developments and Future Plans
Figure 27. Dragonfly Therapeutics Recent Developments and Future Plans
Figure 28. Kiadis Pharma Recent Developments and Future Plans
Figure 29. Nkarta Therapeutics Recent Developments and Future Plans
Figure 30. NantKwest Recent Developments and Future Plans
Figure 31. Global Natural Killer Cell Therapy Revenue Share by Players in 2021
Figure 32. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Natural Killer Cell Therapy Revenue Market Share in 2021
Figure 34. Global Top 10 Players Natural Killer Cell Therapy Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Natural Killer Cell Therapy Revenue Share by Type in 2021
Figure 37. Global Natural Killer Cell Therapy Market Share Forecast by Type (2023-2028)
Figure 38. Global Natural Killer Cell Therapy Revenue Share by Application in 2021
Figure 39. Global Natural Killer Cell Therapy Market Share Forecast by Application (2023-2028)
Figure 40. North America Natural Killer Cell Therapy Sales Market Share by Type (2017-2028)
Figure 41. North America Natural Killer Cell Therapy Sales Market Share by Application (2017-2028)
Figure 42. North America Natural Killer Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 43. United States Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Natural Killer Cell Therapy Sales Market Share by Type (2017-2028)
Figure 47. Europe Natural Killer Cell Therapy Sales Market Share by Application (2017-2028)
Figure 48. Europe Natural Killer Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 49. Germany Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Natural Killer Cell Therapy Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Natural Killer Cell Therapy Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 57. China Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Natural Killer Cell Therapy Sales Market Share by Type (2017-2028)
Figure 64. South America Natural Killer Cell Therapy Sales Market Share by Application (2017-2028)
Figure 65. South America Natural Killer Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Natural Killer Cell Therapy Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Natural Killer Cell Therapy Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Natural Killer Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
